Biogen, Inc. (BIIB)
190.68
+1.55
(+0.82%)
USD |
NASDAQ |
May 06, 16:00
190.84
+0.16
(+0.09%)
After-Hours: 20:00
Biogen SG&A Expense (TTM) : 2.468B for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amgen, Inc. | 6.965B |
| Gilead Sciences, Inc. | 8.398B |
| Johnson & Johnson | 24.60B |
| Eli Lilly & Co. | 11.56B |
| Apellis Pharmaceuticals, Inc. | 550.26M |